Table 1.
Search Terms | Pre-pandemicMean SVI (95% CI) |
PandemicMean SVI (95% CI) |
% Change in SVI | p-value |
---|---|---|---|---|
Cervical cancer | 85.89 (84.74–87.05) | 75.74 (74.01–77.48) | −11.82% | <0.0001* |
Human papillomavirus | 68.98 (67.27–70.69) | 68.15 (66.40–69.90) | −2.62% | 0.5758 |
HPV vaccine | 64.70 (62.94–66.47) | 70.31 (67.31–73.32) | +8.67% | 0.0001* |
Cervarix | 49.42 (45.95–52.88) | 47.88 (44.49–51.27) | −3.12% | 0.7126 |
Gardasil | 62.26 (60.13–64.40) | 60.44 (57.80–63.09) | −2.92% | 0.5587 |
Pap test | 77.02 (75.45–78.59) | 71.42 (68.89–73.96) | −5.99% | 0.0002* |
HPV test | 67.56 (65.14–69.98) | 65.65 (62.77–68.53) | −2.83% | 0.4041 |
Colposcopy | 76.22 (74.47–77.97) | 73.25 (70.15–76.35) | −3.90% | 0.2955 |